Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Launched by INSTITUT PAOLI-CALMETTES · Jun 5, 2019

Keywords

ClinConnect Summary

This clinical trial is studying a new type of medical device called a biodegradable endoprothesis, specifically the Archimede Fast Biodegradable Pancreatic Stent. The goal is to see if this device can help prevent a condition known as Post-Endoscopic Retrograde CholoangioPancreatography (ERCP) Pancreatitis, which can occur after a specific medical procedure used to treat problems in the pancreas and bile ducts. The trial is open to adults over 18 who are considered at higher risk for this complication due to their medical situation.

If you or a family member is interested in participating, you should know that the trial is currently recruiting participants. Eligible individuals will have the stent placed during the ERCP procedure, and researchers will closely monitor how well the device works and how safe it is. However, certain people cannot join, such as those who are pregnant, have recently had acute pancreatitis, or have specific allergies or medical conditions that prevent them from undergoing the procedure. This trial aims to improve care for patients at risk and could lead to better outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age\>18 years
• • Patients at risk of developing a Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis (procedure and/or patient-related risk factors
• Exclusion Criteria:
• • Pregnant or breastfeeding women
• • Recent diagnosis (\<1 month) of acute pancreatitis
• • contraindication to endoscopy
• • Hypersensitivity to indomethacine